Skip to content
Screener

AptarGroup ATR Common Stock

Common Stock at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
200M0.0%
Trimas logo
TrimasTRS
400M0.0%
Silgan Holdings logo
Silgan HoldingsSLGN
$1.75M0.0%
Amcor logo
AmcorAMCR
1.8B-80.0%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
300M0.0%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$1.93M+10.3%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$8.69B-4.7%
Enterprise value$9.9B-2.2%
P/E22.5×-0.8×
P/S2.3×-0.3×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:22 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000896622-26-000092
In thousands, except share and per share amountsMarch 31, 2026December 31, 2025
Redeemable Noncontrolling Interests26,69426,244
Total Mezzanine Equity26,69426,244
AptarGroup, Inc. stockholders’ equity:
Common stock, $.01 par value, 199.0 million shares authorized, 73.1 million and 72.8 million shares issued as of March 31, 2026 and December 31, 2025, respectively731728
Capital in excess of par value1,192,7051,165,518
Retained earnings2,684,3822,642,552
Accumulated other comprehensive loss(198,716)(186,382)
Less: Treasury stock at cost, 9.2 million and 8.6 million shares as of March 31, 2026 and December 31, 2025(1,049,607)(954,320)

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's common stock?
AptarGroup (ATR) reported common stock of 199M in Q1 2026.
How has AptarGroup's common stock changed year-over-year?
AptarGroup's common stock decreased by 0.0% year-over-year, from 199M to 199M.
What is the long-term trend for AptarGroup's common stock?
Over 5 years (2020 to 2025), AptarGroup's common stock has grown at a 210.0% compound annual growth rate (CAGR), from 695K to 199M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Ask your AI about AptarGroup's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude